medindia

In Murine Osteoporosis, Choloroquine Reduces Formation of Bone Resorbing Cells

by Bidita Debnath on  December 12, 2013 at 10:48 PM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

Bone homeostasis requires precise balance between resorption of old bone by osteoclasts and deposition of new bone by osteoblasts.
In Murine Osteoporosis, Choloroquine Reduces Formation of Bone Resorbing Cells
In Murine Osteoporosis, Choloroquine Reduces Formation of Bone Resorbing Cells

Bone diseases, including osteoporosis and rheumatoid arthritis, are the result of increased osteoclast activity and formation, which allows bone resorption to outpace deposition. In this issue of the Journal of Clinical Investigation, Brendan Boyce and colleagues at the University of Rochester evaluated the role of TNF receptor-associated receptor 3 (TRAF3) in promoting osteoclast formation.

Show Full Article


Mice lacking TRAF3 in osteoclast precursor cells had mild osteoporosis that was associated with increased osteoclast formation. The authors found that chloroquine treatment increased TRAF3 in osteoclast precursor cells and limited osteoclast generation. Furthermore, treatment of mouse models of osteoporosis with chloroquine inhibited osteoclast formation. These studies implicate that therapies aimed at increasing TRAF3 in osteoclast precursor cells may limit bone loss for those with bone diseases.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Most Popular On Medindia:

Find a Hospital

Find a Hospital

Sanatogen

Sanatogen

Fongitar (Zinc Pyrithionone)

Fongitar (Zinc Pyrithionone)

Recommended Reading

Research may Explain Fractures in Some Who Take Osteoporosis Drugs

At the Texas Biomedical Research Institute, research with baboons may help explain why some people who take bone-strengthening drugs like bisphosphonates are at-risk for atypical fractures in the long bones in their legs.

Nearly 22 Million Aged Women are Affected by Osteoporosis in the European Union

More than 22 million women aged between 50-84 years in the European Union (EU) have osteoporosis, estimates a recent report issued by the International Osteoporosis Foundation (IOF).

Statin Osteoporosis Drug Combo Could Treat Parasitic Infections

A combo of two drugs prescribed for high cholesterol and osteoporosis could be a new treatment for toxoplasmosis, a parasitic infection, researchers found

Osteoporosis Drug Stops Growth of Breast Cancer Cells

A drug used to treat osteoporosis has now been shown to stop the growth of breast cancer cells, finds study.

Infantile Cortical Hyperostosis

Infantile Cortical Hyperostosis is a disease of unknown cause, where bizarre thickening of the cortical bones of infants is the prime finding

Osteoporosis

Osteoporosis is a bone disease that leads to an increased risk of fractures. The bone mass is reduced and the bones are porous, thereby resulting in weakness of the skeletal system of the body.

Renal Osteodystrophy / Mineral Bone Disorder

Renal Osteodystrophy which is referred to as Mineral Bone Disorder is a result of imbalance in calcium, phosphorus, parathyroid hormone and Vitamin D levels.

More News on:

OsteoporosisInfantile Cortical HyperostosisParkinsons Disease Surgical TreatmentRenal Osteodystrophy / Mineral Bone Disorder

What's New on Medindia

Chemical Castration

Kidney Stones can Now be Removed Easily and Painlessly

Anal Cancer
View All

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive